Telomere Length as a Potential Biomarker for Hepatocellular Carcinoma: A Comparative Analysis of Patients with HCV Treated with Direct Antiviral Agents - Top-Institutions - MDSpire

Telomere Length as a Potential Biomarker for Hepatocellular Carcinoma: A Comparative Analysis of Patients with HCV Treated with Direct Antiviral Agents

  • By

  • Marwa Helal

  • Marwa Gamal

  • Ashraf A. Basuni

  • Walaa El Gendy

  • Ashraf Khalil

  • February 23, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Hepatology
    • Oncology
    • Molecular Biology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hepatology
    • Gastroenterology
    • Oncology

  • #3

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Hepatology
    • Cancer Biology
    • Virology

  • #4

    National Cancer Institute (NCI), NIH
    National Cancer Institute (NCI), NIH

    Bethesda, MD

    Key Differentiators

    • Cancer Research
    • Molecular Oncology
    • Virology

  • #5

    Mount Sinai Health System
    Mount Sinai Health System

    New York, NY

    Key Differentiators

    • Hepatology
    • Oncology
    • Translational Medicine

Original Source(s)

Telomere Length as a Potential Biomarker for Hepatocellular Carcinoma: A Comparative Analysis of Patients with HCV Treated with Direct Antiviral Agents

  • by Marwa Helal, Marwa Gamal, Ashraf A. Basuni, Walaa El Gendy, Ashraf Khalil

  • February 23, 2026

Related Content

Immunological research landscapes and emerging immune mechanisms in HIV/HBV co-infection: a bibliometric analysis (2014–2024)

Meet Saro Khemichian, MD

Saro Khemichian, MD, is a transplant hepatologist with the USC Transplant Institute, part of Keck Medicine of USC, who cares for patients across the full spectrum of liver diseases, from mild liver conditions to advanced cirrhosis and liver failure, including those who have undergone a liver transplant.

  • by

  • April 27, 2026

  • 6 min
Editorial: Digital technologies in hepatology: diagnosis, treatment, and epidemiological insights